Should I Buy NTRA? NTRA 2026 Analysis

Should You Buy Natera Inc (NTRA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

231.480

1 Day change

-1.89%

52 Week Range

256.360

Analysis Updated At

2026/01/26

Natera Inc (NTRA) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong growth trajectory, positive analyst sentiment, and bullish long-term price targets outweigh the short-term technical and insider selling concerns.

Technical Analysis

The technical indicators are mixed. The MACD is below zero and negatively contracting, indicating bearish momentum. However, the RSI is neutral at 56.826, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 228.936, and resistance is at 247.18. The stock is trading near its pivot level of 238.058.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Hedge funds are significantly increasing their holdings in Natera, with a 265.72% increase in buying over the last quarter.
Analysts are highly bullish, with multiple price target increases and Buy ratings, indicating strong confidence in the company's growth potential.
The company's Q3 2025 financials show robust revenue growth of 34.66% YoY and significant improvements in net income and EPS.

Neutral/Negative Catalysts

Insiders are selling heavily, with a 1307.77% increase in selling activity over the last month.
The MACD indicator suggests bearish momentum in the short term.
No recent congress trading data or AI/SwingMax trading signals to support immediate entry.

Financial Performance

In Q3 2025, Natera reported a 34.66% YoY increase in revenue to $592.18 million. Net income improved significantly, up 177.11% YoY to -$87.54 million, and EPS improved by 146.15% YoY to -0.64. Gross margin increased to 64.91%, up 5.05% YoY, indicating strong operational efficiency.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are overwhelmingly positive on Natera. Recent upgrades include price targets ranging from $260 to $300, with consistent Buy and Overweight ratings. Analysts highlight Natera's dominant position in the molecular residual disease market and its growth potential in women's and organ health markets.

17 Analyst Rating

Wall Street analysts forecast NTRA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NTRA is 252.88 USD with a low forecast of 172 USD and a high forecast of 300 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

15 Buy

2 Hold

0 Sell

Strong Buy

Current: 235.930

Low

172

Averages

252.88

High

300

Current: 235.930

Low

172

Averages

252.88

High

300

TD Cowen

Buy

maintain

$240 -> $280

AI Analysis

2026-01-07

Reason

TD Cowen

Price Target

$240 -> $280

AI Analysis

2026-01-07

maintain

Buy

Reason

TD Cowen raised the firm's price target on Natera to $280 from $240 and keeps a Buy rating on the shares. The firm adjusted targets in the diagnostics group as part of a Q4 preview. It expects solid results and 2026 outlooks for the sector, saying strong fundamentals remain.

Citi

NULL -> Buy

initiated

$300

2026-01-07

Reason

Citi

Price Target

$300

2026-01-07

initiated

NULL -> Buy

Reason

Citi initiated coverage of Natera with a Buy rating and $300 price target. The company is an "established player" in the women's and organ health markets, but its "dominant position" in the growing molecular residual disease market is the focus for investors, the analyst tells investors in a research note. Citi believes the shares warrant a premium multiple with a "significant" growth runway ahead for Natera.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for NTRA

Unlock Now

NTRA Should I Buy

NTRA Should I Buy

Should You Buy Natera Inc (NTRA) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch